Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD

Long-acting muscarinic antagonist (LAMA) or long-acting β2-agonist (LABA) bronchodilators and their combination are recommended for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Although the efficacy of LAMAs and LABAs has been well established through randomized control...

Descripción completa

Detalles Bibliográficos
Autores principales: Kardos, Peter, Worsley, Sally, Singh, Dave, Román-Rodríguez, Miguel, Newby, David E, Müllerová, Hana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135074/
https://www.ncbi.nlm.nih.gov/pubmed/27932872
http://dx.doi.org/10.2147/COPD.S118867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135074/
https://www.ncbi.nlm.nih.gov/pubmed/27932872
http://dx.doi.org/10.2147/COPD.S118867

Ejemplares similares